Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alicia Padilla Galo, Marina Labor, Angelica Tiotiu, Ilaria Baiardini, Nicola Scichilone & Fulvio Braido. (2018) Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives. Patient Related Outcome Measures 9, pages 267-273.
Read now
Read now
Garry M. Walsh. (2017) Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma – an update. Expert Review of Clinical Immunology 13:2, pages 143-149.
Read now
Read now
Girolamo Pelaia, Alessandro Vatrella, Maria Teresa Busceti, Luca Gallelli, Mariaimmacolata Preianò, Nicola Lombardo, Rosa Terracciano & Rosario Maselli. (2016) Role of biologics in severe eosinophilic asthma – focus on reslizumab. Therapeutics and Clinical Risk Management 12, pages 1075-1082.
Read now
Read now
Con Panousis, Urmi Dhagat, Kirsten M. Edwards, Veronika Rayzman, Matthew P. Hardy, Hal Braley, Gail M. Gauvreau, Timothy R. Hercus, Steven Smith, Roma Sehmi, Laura McMillan, Mara Dottore, Barbara J. McClure, Louis J. Fabri, Gino Vairo, Angel F Lopez, Michael W. Parker, Andrew D. Nash, Nicholas J. Wilson, Michael J. Wilson & Catherine M. Owczarek. (2016) CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors. mAbs 8:3, pages 436-453.
Read now
Read now
Juan Carlos Cardet & Elliot Israel. (2015) Update on reslizumab for eosinophilic asthma. Expert Opinion on Biological Therapy 15:10, pages 1531-1539.
Read now
Read now
Articles from other publishers (5)
Sheikh Rayees & Inshah DinSheikh Rayees & Inshah Din. 2021. Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions. Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions
27
32
.
Sheikh Rayees & Inshah DinSheikh Rayees & Inshah Din. 2021. Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions. Asthma: Pathophysiology, Herbal and Modern Therapeutic Interventions
35
36
.
N I Ilina, N M Nenasheva, S N Avdeev, Z R Aisanov, V V Arkhipov, A A Vizel, A V Emelyanov, N P Knyazheskaya, O M Kurbacheva, I V Leshchenko, G L Osipova, E A Styrt, O N Titova, R S Fassakhov & S V Fedosenko. (2017) Algorithm of biophenotyping and choice of medication for targeted therapy of severe uncontrolled asthma with eosinophilic type of airways inflammation. Russian Journal of Allergy 14:3, pages 5-18.
Crossref
Crossref
Garry M. Walsh. (2016) Monoclonal Antibody-Based Therapy for Eosinophilic Oesophagitis. EMJ Gastroenterology, pages 125-129.
Crossref
Crossref
Sebastian Heck, Juliane Nguyen, Duc-Dung Le, Robert Bals & Quoc Thai Dinh. (2015) Pharmacological Therapy of Bronchial Asthma: The Role of Biologicals. International Archives of Allergy and Immunology 168:4, pages 241-252.
Crossref
Crossref